Invention Grant
- Patent Title: Cyclic dinucleotides as anticancer agents
-
Application No.: US16642424Application Date: 2018-08-30
-
Publication No.: US10953032B2Publication Date: 2021-03-23
- Inventor: Dharmpal S. Dodd , Brian E. Fink , Yong Zhang
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2018/048666 WO 20180830
- International Announcement: WO2019/046500 WO 20190307
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K31/708 ; A61K39/395
Abstract:
The present invention is directed to compounds of the formula (I) wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
- US20200253997A1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Public/Granted day:2020-08-13
Information query
